| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_461514df460e0cdd5644e86ba60adbf7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate |
2020-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32543d42d0b1b1b4f1220f1de8931a81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7133ae6c207ddc0f3667fe771d2efb8 |
| publicationDate |
2021-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202116325-A |
| titleOfInvention |
Method and pharmaceutical composition for prevention and treatment of a cancer |
| abstract |
The invention relates to a method or pharmaceutical composition for prevention and/or treatment of a cancer, comprising administering to the subject a therapeutically effective amount of a compound selected from the group consisting of 3[alpha],5[alpha]-Tetrahydrocorticosterone (5[alpha]-THB) and 3[alpha],5[beta]-Tetrahydrocorticosterone (5[beta]-THB). |
| priorityDate |
2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |